Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer. Read more about Receiver operating curves and dose-volume analysis of late toxicity with stereotactic body radiation therapy for prostate cancer.
Failure mode and effects analysis in a dual-product microsphere brachytherapy environment. Read more about Failure mode and effects analysis in a dual-product microsphere brachytherapy environment.
Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway. Read more about Delineation of radiation therapy target volumes for cutaneous malignancies involving the ophthalmic nerve (cranial nerve V-1) pathway.
American College of Radiology (ACR) Radiation Oncology Practice Accreditation: A pattern of change. Read more about American College of Radiology (ACR) Radiation Oncology Practice Accreditation: A pattern of change.
The softer (and furrier) side of oncology. Read more about The softer (and furrier) side of oncology.
Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy. Read more about Enhancing safety and quality through preplanning peer review for patients undergoing stereotactic body radiation therapy.
SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer. Read more about SBRT and HDR brachytherapy produce lower PSA nadirs and different PSA decay patterns than conventionally fractionated IMRT in patients with low- or intermediate-risk prostate cancer.
Absence of physiologic breast response to pregnancy and lactation after radiation therapy. Read more about Absence of physiologic breast response to pregnancy and lactation after radiation therapy.
Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer. Read more about Dose-volume analysis and the temporal nature of toxicity with stereotactic body radiation therapy for prostate cancer.
Quality improvement of International Classification of Diseases, 9th revision, diagnosis coding in radiation oncology: single-institution prospective study at University of California, San Francisco. Read more about Quality improvement of International Classification of Diseases, 9th revision, diagnosis coding in radiation oncology: single-institution prospective study at University of California, San Francisco.
